Compounds > oseltamivir
Page last updated: 2024-08-24

oseltamivir and naproxen

oseltamivir has been researched along with naproxen in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's3 (30.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Alessi, MC; Bertrand, HC; Chebbo, M; Companys, S; Dilly, S; Fotso Fotso, A; Lejal, N; Noiray, M; Quideau, S; Rahman, F; Riteau, B; Slama-Schwok, A; Tarus, B; Vidic, J; Zedda, G1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Chan, JFW; Chan, KH; Chan, TC; Chen, H; Cheng, VCC; Cheung, MKS; Fok, M; Hung, IFN; Lau, JYN; Leung, W; Li, P; Liu, KSH; Tam, A; To, KKW; Wong, TL; Yuen, KY; Zhang, AJ; Zhang, R1
Mazzetti, A; Neary, JD1
Hung, IFN; Yuen, KY1
Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N1
Chi, H; Chiu, NC; Huang, CY; Huang, DT; Huang, FY; Huang, LM; Lee, CW; Tai, YL; Tu, YH; Wang, JY1

Reviews

1 review(s) available for oseltamivir and naproxen

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for oseltamivir and naproxen

ArticleYear
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
    Chest, 2017, Volume: 151, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Clarithromycin; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Length of Stay; Male; Mortality; Naproxen; Nasopharynx; Oseltamivir; Severity of Illness Index; Treatment Outcome; Viral Load

2017

Other Studies

8 other study(ies) available for oseltamivir and naproxen

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus.
    Journal of medicinal chemistry, 2018, 08-23, Volume: 61, Issue:16

    Topics: A549 Cells; Animals; Antiviral Agents; Binding Sites; Cyclooxygenase 2 Inhibitors; Dogs; Drug Design; Drug Repositioning; Drug Resistance, Viral; Female; Humans; Influenza A virus; Influenza, Human; Madin Darby Canine Kidney Cells; Mice, Inbred C57BL; Molecular Docking Simulation; Naproxen; Nucleocapsid Proteins; Oseltamivir; RNA-Binding Proteins; Surface Plasmon Resonance; Viral Core Proteins

2018
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Outcome Switching in Triple Therapy in Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
    Chest, 2018, Volume: 154, Issue:4

    Topics: Clarithromycin; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Naproxen; Oseltamivir

2018
Response.
    Chest, 2018, Volume: 154, Issue:4

    Topics: Clarithromycin; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Naproxen; Oseltamivir

2018
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2

    Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin

2020
Efficacy of clarithromycin-naproxen-oseltamivir combination therapy versus oseltamivir alone in hospitalized pediatric influenza patients.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Influenza, Human; Male; Naproxen; Oseltamivir; Prospective Studies; Single-Blind Method; Treatment Outcome; Viral Load

2021